Status:
NOT_YET_RECRUITING
Using Dry Eye As a Disease Model, Investigators Demonstrated the Optimal Selection of Individualized Clinical Interventions and the Superiority of Dynamic Treatment Discrimination in Chinese Medicine.
Lead Sponsor:
Xuejing Lu
Conditions:
Dry Eye Disease (DED)
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In this study, dry eye disease (leukoaraiosis) is used as a model disease, and the methodological system for evaluating the clinical efficacy of Chinese medicine for dry eye disease is constructed wit...
Eligibility Criteria
Inclusion
- Be 18-75 years of age and of any gender
- Meets Western diagnostic criteria for dry eye
- Formed consent and signed the Informed Consent Form
Exclusion
- Those who are unable to perform a dry eye examination due to various factors
- Patients with severe diseases of the liver or renal system, or infectious eye diseases
- Those who are allergic to the medications used in this study
- Women who are pregnant or breastfeeding Mental illness or intellectual disability; Participants in clinical trials of other drugs within the last 3 months.
Key Trial Info
Start Date :
September 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT06605495
Start Date
September 25 2024
End Date
October 1 2025
Last Update
September 24 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.